Obesity and pulmonary function in Navajo and Hopi children

Joey C Eisenmann1, David A Arnall, Verdell Kanuho

  • 1Department of Health and Human Performance, Iowa State University, Ames, IA 50010, USA. jce@iastate.edu

Ethnicity & Disease
|February 6, 2007
PubMed

Insights

Childhood obesity negatively impacts lung function in Navajo and Hopi children. Obese children showed decreased pulmonary function (forced vital capacity, forced expiratory volume) compared to normal-weight peers.

Area of Science:

  • Pediatric Pulmonology
  • Obesity Research
  • Native American Health

Background:

  • Childhood obesity is linked to cardiovascular and metabolic risks.
  • Limited research exists on childhood obesity's effects on pulmonary function.

Purpose of the Study:

  • To investigate the impact of obesity on lung function in Navajo and Hopi children.
  • To analyze pulmonary function metrics in relation to weight status.

Main Methods:

  • 813 Navajo and Hopi children (ages 6-12) were classified by BMI (normal, overweight, obese).
  • Pulmonary function tests including forced vital capacity (FVC) and forced expiratory volume in one second (FEV1) were performed.
  • Measurements followed American Thoracic Society standards.

Main Results:

  • 16% of children were obese; overweight children showed increased pulmonary function.
  • Obese children exhibited reduced pulmonary function compared to normal-weight children.
  • Significant differences in FEV1%, FEF25-75 (boys), FVC, and FEV1 (girls) were observed across weight groups.

Conclusions:

  • Pediatric obesity has detrimental pulmonary consequences.
  • Findings highlight adverse health outcomes of obesity in Native American children.
  • Supports the need for interventions addressing childhood obesity and its respiratory effects.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...